Skip to content

ASCLEPIA MED

Active
Private limited companyfounded 2025active for 1 yearRue des Hirondelles 19, 6001 Charleroi, BelgiumKBO/BCE: BE 1025.704.229
Summary

ASCLEPIA MED has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16,091 and a net result of €12,091. Its solvency ranks better than 39% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 18-07-2025 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.377.286.985 6001 Charleroi, since 18-07-2025
Financial year end
31 December
Peppol
Reachable since 22-12-2025

Board and ownership

Board
Shareholders
  • BEUKEN Sophie Marie Emilieact of 23-07-2025

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€20,703
Turnover
≈ €130,000
estimated
Profit
€12,091
Equity
€16,091
Total assets
€32,519
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.60, cash €15,050Figures for financial year 2025 (filed on 09-07-2026)Size: total assets €32,519Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 61% of micro companies in human health (NACE 86)
Financial strength
Strong
Solvency 74
equity 49.5% of total assets
Liquidity 80
short-term debt 42.1% · cash 46.3%
Profitability 100
return on assets 37.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 08-2026: < 0.1%lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.6, above the usual 1.5. Short-term debt is 42.1% and cash 46.3% of total assets. However, 50.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 40% of them on solvency, 62% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.60, cash €15,050
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 09-07-2026)
NBB · annual accounts
lowers risk · Size: total assets €32,519
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-07-2026, 22 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
22 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Caution: Less equity than 85% of companies in human healthsector median €124,634 · 20,722 companies €16,091 View

Recent changes

  1. · Gazette deed IncorporationFounding capital of €4,000, 400 shares · Founder: BEUKEN Sophie Marie Emilie · Appointment: BEUKEN Sophie Marie Emilie (director)
All 2 events

Comparable companies

These companies have the same main activity as ASCLEPIA MED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €25,400 and €33,200, founded in 2025.

CompanyTotal assetsGross margin
ASCLEPIA MED Charleroi€32,519€20,703
DOCTEUR BOUZID JESSICA Chaudfontaine€33,183€20,566
DR. LOURDAUX PIETER-JAN Lommel€28,742€20,196
Dr. Jules Hellemans Gent€30,079€19,013
Dr. Arne Nevens Schoten€28,313€20,872
CLINIQUE S2 Charleroi€25,443€24,282
GOMEDIC Namur€27,178€20,020
Full comparison

Key facts about ASCLEPIA MED

What is the company number of ASCLEPIA MED?
The company number of ASCLEPIA MED is 1025.704.229. The VAT number is the same number with BE in front: BE 1025.704.229.
Where is ASCLEPIA MED based?
The registered office is at Rue des Hirondelles 19, 6001 Charleroi.Company details
What does ASCLEPIA MED do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of ASCLEPIA MED?
The legal form of ASCLEPIA MED is Private limited company (BV).
When was ASCLEPIA MED founded?
ASCLEPIA MED was founded on 18-07-2025.
Is ASCLEPIA MED still active?
Yes, ASCLEPIA MED is an active enterprise in the KBO register.
What is the turnover of ASCLEPIA MED?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €20,703 and 48 comparable companies (NACE 86). It probably lies between €89,000 and €220,000. It is a rough estimate.Financials
Is ASCLEPIA MED profitable?
In financial year 2025, ASCLEPIA MED made a profit of €12,091.
Where can I find the annual accounts of ASCLEPIA MED?
ASCLEPIA MED filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.